Literature DB >> 26444605

Association of whole blood viscosity with non-alcoholic fatty liver disease.

Xin-Yang Yu1, Ying Li2, Tiemin Liu3, Rui-Tao Wang4.   

Abstract

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is an independent risk factor for increased cardiovascular disease. Altered hemorheological parameters have also been shown to play a crucial role in atherogenesis. Moreover, increased viscosity is observed in insulin resistance, metabolic syndrome, hypertension, diabetes, ischemic heart disease, and stroke. A recent study confirmed that whole blood viscosity (WBV) is a predictor of cardiovascular events. AIMS: This study aimed to investigate the association of WBV with NAFLD.
METHODS: In this cross-sectional study, we investigated the relationship between WBV and NAFLD in 1329 subjects (962 men and 367 women) in a general health examination.
RESULTS: WBV at low shear stress was elevated in patients with NAFLD. In addition, the prevalence of metabolic syndrome and NAFLD increased as WBV quartiles increased both in men and in women. Multiple regression analysis further identified WBV as an independent and significant determinant for NAFLD.
CONCLUSIONS: The findings showed that WBV at low shear stress is increased in NAFLD. Moreover, WBV at low shear stress is independently associated with NAFLD even after adjusting other cardiovascular risk factors.

Entities:  

Keywords:  Whole blood viscosity; metabolic syndrome; non-alcoholic fatty liver disease

Mesh:

Year:  2015        PMID: 26444605     DOI: 10.3233/CH-151974

Source DB:  PubMed          Journal:  Clin Hemorheol Microcirc        ISSN: 1386-0291            Impact factor:   2.375


  3 in total

1.  Whole blood viscosity is associated with extrahepatic metastases and survival in patients with hepatocellular carcinoma.

Authors:  Ji Won Han; Pil Soo Sung; Jeong Won Jang; Jong Young Choi; Seung Kew Yoon
Journal:  PLoS One       Date:  2021-12-02       Impact factor: 3.240

Review 2.  Endothelial Cell Dysfunction and Nonalcoholic Fatty Liver Disease (NAFLD): A Concise Review.

Authors:  Narjes Nasiri-Ansari; Theodoros Androutsakos; Christina-Maria Flessa; Ioannis Kyrou; Gerasimos Siasos; Harpal S Randeva; Eva Kassi; Athanasios G Papavassiliou
Journal:  Cells       Date:  2022-08-12       Impact factor: 7.666

3.  Hemorheological Alteration in Patients Clinically Diagnosed with Chronic Liver Diseases.

Authors:  Bohyun Jang; Ji Won Han; Pil Soo Sung; Jeong Won Jang; Si Hyun Bae; Jong Young Choi; Young I Cho; Seung Kew Yoon
Journal:  J Korean Med Sci       Date:  2016-12       Impact factor: 2.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.